Get started
Author

Colin S. Burdette

Observed name: Colin Burdette
ORCID: 0009-0007-5571-6822
Observed ORCID: 0009-0007-5571-6822
OpenAlex ID: A5107569929
GPCR Biosensors to Study Conformational Dynamics and Signaling in Drug Discovery
2025 · Victoria R. Saca, Colin Burdette, et al. · The Annual Review of Pharmacology and Toxicology · 17
Global protein-ligand binding affinity profiling via photocatalytic labeling
2026 · Charles D. Warren, Noah Yardeny, et al. · Nature Communications · 6
PDF
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al. · Cancer Discovery · 2
PDF
Carbocation-Based Proximity Labeling
2026 · Colin S. Burdette, Adam M. Cohen, et al. · ChemRxiv · 1
Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma
2026 · Yura Seo, Yoon Dae Han, et al. · Journal of Extracellular Vesicles · 1
Targeted degradation of a constitutively active GPCR oncoprotein
2026 · Victoria R. Saca, Yuanhuang Chen, et al. · iScience
PDF
AR-V7 Utilizes a Noncanonical Nuclear Localization Signal to Sustain Androgen-Independent Nuclear Import and Signaling
2026 · Urko del Castillo, Naira E. Abou-Ghali, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S7 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Data from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026 · Benedikt Pelzer, Cem Meydan, et al.
Works count: 35
Citation count: 27
H-index: 2
I10-index: 1
Year
Topic
Type